Home Healthcare Medical Devices Mobile Cardiac Telemetry Systems Market

Mobile Cardiac Telemetry Systems Market Size, Share & Trends Analysis Report By Product Type (Multiple Lead Mobile Cardiac Telementry Systems, Mobile Cardiac Telemetry Patch), Application (Lead-based, Patch-based), End-Use (Hospitals, Cardiac centres, Home Care Settings, Others), By Diseases (Cardiovascular Diseases, Angina Pectoris, Atherosclerosis, Heart Failure, Other) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Mobile Cardiac Telemetry Systems Market Size

The global mobile cardiac telemetry systems market size was valued at USD 1342.01 million in 2025 and is projected to grow from USD 1509.09 million in 2026 to USD 3858.25 million by 2034, registering a CAGR of 12.45% during the forecast period from 2026 to 2034. North America dominated the mobile cardiac telemetry systems market with a market share of 42.35% in 2025.

The patient wears mobile cardiac telemetry (MCT) devices, which are small, portable sensors used to track heart rhythm. When a cardiac rhythm anomaly is found, the sensor notifies the transmitter, who then relays the information over a mobile network to the manned monitoring centre. As various bodily activities can be comprehended by carefully examining the heart rhythm, cardiac monitoring is a crucial component of healthcare diagnostics. One of the most recent advancements in cardiac monitoring is mobile cardiac telemetry, which enables remote monitoring of patients who are located distant from their doctors.

Mobile Cardiac Telemetry Systems Market Size

Download a Free Sample To learn more about this report.

Applications Insights

This market can be segmented on the basis of applications, end-users, regions and competitors. Due to the light weight and user-friendliness of lead-based MCTs, which are preferred by many patients, the lead-based segment led the market for mobile cardiac telemetry systems in 2021 and held a revenue share of over 65.0%. Lead failure and telemetry disruption are just a couple of the drawbacks that come with lead-based MCTs and may prevent them from expanding in the ensuing years.

Over the course of the forecast period, the patch-based segment is anticipated to grow profitably in the mobile cardiac telemetry systems market. For the measurement and monitoring of bradyarrhythmia and tachyarrhythmia, patch-based Continuous Cardiac Rhythm Monitoring (CCRM) has become a helpful clinical tool in the outpatient context. These patch-based CRM devices have been researched in the outpatient setting as an alternative to conventional Holter monitoring and have shown to be workable and patient-friendly solutions for the detection of clinically significant arrhythmia, which is driving the demand.

Mobile Cardiac Telemetry Systems Market Size By Segments

Request Customizationto receive a tailored report.

End-Use Insights

In 2021, the hospital sector, which had a revenue share of more than 60.0%, dominated the market for mobile cardiac telemetry systems. The rise in minimally invasive procedures performed in these facilities can be blamed for the expansion. Hospitals are also more convenient than other facilities because they are ubiquitous and simple to access. The demand is also anticipated to increase in the coming years due to advantageous reimbursement regulations.

The hospital, cardiac centre, and other end-use markets for mobile cardiac telemetry systems are divided. Over the projected period, it is anticipated that the cardiac centre category will grow the fastest. The rise in cardiac centres and the easy access to surgeons working for these hospitals are to blame for the expansion. Due to an increase in demand for outpatient services, ambulatory surgery facilities are also anticipated to grow in popularity during the projection period. The category is growing as a result of several causes, including less expensive treatment and shorter stays.

Mobile Cardiac Telemetry Systems Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Analysis

A revenue share of about 37.0% went to North America in 2021, which dominated the market for mobile cardiac telemetry systems. The incidence of heart illnesses, the growing senior population, and rising healthcare costs are only a few of the factors contributing to this development. For example, the elderly population in the United States has increased by 33% over the past ten years, according to data released by the Administration for Community Living. Additionally, the existence of significant service providers with enhanced healthcare solutions is anticipated to drive market expansion during the anticipated period.

North America Mobile Cardiac Telemetry Systems Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Region Are Anticipated to Grow at A Healthy Cagr

Mobile cardiac telemetry system sales in the Asia Pacific region are anticipated to grow at a healthy CAGR of almost 13.5% during the forecast period. Cardiovascular morbidities have increased in the area as a result of factors including dietary practices and the rising adoption of a sedentary lifestyle that results in physical inactivity. Cardiovascular disorders are thought to be responsible for over 170,000 fatalities in Japan each year, according to the Ministry of Health, Labor, and Welfare. In addition, a number of international corporations are establishing manufacturing operations in the area because of the affordable production prices and the availability of competent workers. The previously mentioned elements are further increasing the demand for transportable cardiac telemetry equipment.

List of Key and Emerging Players in Mobile Cardiac Telemetry Systems Market

Applied Cardiac Systems Inc.
Medicomp Inc.
Preventice Solutions
Telerhythmics LLC
Zoll Medical Corporation
iRhythm Technologies Inc.
ScottCare
Biotricity Inc.
Welch Allyn
BioTelemetry Inc.

Key Industry Developments

September 2025
Philips entered a national partnership with Optum Healthcare to make its Mobile Cardiac Telemetry (MCOT) and Extended Holter (ePatch) solutions available to approximately 3.4 million Optum members, expanding access to ambulatory cardiac monitoring across the U.S.
September 2025
Philips launched its next-generation Telemetry Monitor 5500 as part of its Smart Telemetry Platform, enhancing enterprise-wide cardiac monitoring and supporting seamless transition to Philips Mobile Cardiac Telemetry (MCOT) for post-discharge patients.

Report Scope

Segmentation

By Product Type 2
  • Multiple Lead Mobile Cardiac Telementry Systems
  • Mobile Cardiac Telemetry Patch
Application 2
  • Lead-based
  • Patch-based
End-Use 4
  • Hospitals
  • Cardiac centres
  • Home Care Settings
  • Others
By Diseases 5
  • Cardiovascular Diseases
  • Angina Pectoris
  • Atherosclerosis
  • Heart Failure
  • Other

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Applied Cardiac Systems Inc. · Medicomp Inc. · Preventice Solutions · Telerhythmics LLC · Zoll Medical Corporation
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The mobile cardiac telemetry systems market size is valued at USD 1509.09 Million in 2026 and is projected to reach USD 3858.25 Million by 2034, at a CAGR of 12.45% during the forecast period 2026-2034.

North America dominated the market with a share of 42.35% in 2025.

The leading players in this market are Applied Cardiac Systems Inc., Medicomp Inc., Preventice Solutions, Telerhythmics LLC, Zoll Medical Corporation.

The mobile cardiac telemetry systems market is projected to grow at a CAGR of 12.45% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: